ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment

Bibliographic Details
Title: ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment
Authors: Zhenbo Han, Zihang Xu, Ying Yu, Yang Cao, Zhengyi Bao, Xinlu Gao, Danyu Ye, Gege Yan, Rui Gong, Juan Xu, Lai Zhang, Wenya Ma, Xiuxiu Wang, Fan Yang, Hong Lei, Ye Tian, Shijun Hu, Djibril Bamba, Ying Li, Desheng Li, Changzhu Li, Ning Wang, Ying Zhang, Zhenwei Pan, Baofeng Yang, Benzhi Cai
Source: Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 22-33 (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: Therapeutics. Pharmacology, RM1-950
More Details: N6-methyladenosine (m6A), as the most abundant modification of mammalian messenger RNAs, is essential for tissue development and pathogenesis. However, the biological significance of m6A methylation in cardiac differentiation and development remains largely unknown. Here, we identify that the downregulation of m6A demethylase ALKBH5 is responsible for the increase of m6A methylation and cardiomyocyte fate determination of human embryonic stem cells (hESCs) from mesoderm cells (MESs). In contrast, ALKBH5 overexpression remarkably blocks cardiomyocyte differentiation of hESCs. Mechanistically, KDM5B and RBBP5, the components of H3K4 modifying enzyme complexes, are identified as downstream targets for ALKBH5 in cardiac-committed hESCs. Loss of function of ALKBH5 alters the expression of KDM5B and RBBP5 through impairing stability of their mRNAs, which in turn promotes the transcription of GATA4 by enhancing histone H3 Lys4 trimethylation (H3K4me3) at the promoter region of GATA4. Taken together, we reveal a previously unidentified role of m6A demethylase ALKBH5 in determining cardiac lineage commitment of hESCs.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2162-2531
Relation: http://www.sciencedirect.com/science/article/pii/S2162253121001359; https://doaj.org/toc/2162-2531
DOI: 10.1016/j.omtn.2021.05.019
Access URL: https://doaj.org/article/84567e9099184ddf8b22062dfe37de9c
Accession Number: edsdoj.84567e9099184ddf8b22062dfe37de9c
Database: Directory of Open Access Journals
More Details
ISSN:21622531
DOI:10.1016/j.omtn.2021.05.019
Published in:Molecular Therapy: Nucleic Acids
Language:English